Allergy Therapeutics says peanut allergy drug early trials promising
(Alliance News) - Allergy Therapeutics PLC on Wednesday said its combined phases 1 and 2a trial shows its potential treatment for peanut allergy supports a "strong immunomodulating potential" for the product. Read More